Bothhigh density lipoprotein cholesterol (HDL-C) and its subfraction were decreased.

高密度脂蛋白胆固醇(HDL - c)及其亚组分均降低。

youdao

It can decrease the concentration of HDL-C thus plays an auxo-action for regression of atherosclerosis.

菲律宾蛤仔还可减慢HDL-C浓度下降，对动脉粥样硬化消退起促进作用。

youdao

Multivariate analysis revealed that the drop in LDL-C and increase in HDL-C both independently predicted atheroma regression.

多变量分析显示LDL - C水平的降低以及HDL - C水平的增加各自都能改善动脉粥样硬化。

youdao

The addition of Kynamro helps to reduce low-density lipoprotein-cholesterol (LDL-C), apolipoprotein B, total cholesterol, and non-high density lipoprotein-cholesterol (non HDL-C).

FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

In December 2012, the FDA approved Juxtapid (lomitapide) to reduce LDL-C, total cholesterol, apolipoprotein B, and non HDL-C in patients with HoFH.

FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

KYNAMRO, given as a 200 mg weekly subcutaneous injection, has been approved as an adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (Apo B), total cholesterol (TC), and non-high density lipoprotein-cholesterol (non HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).

FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia